15 Jul, EOD - Indian

SENSEX 80664.86 (0.18)

Nifty 50 24586.7 (0.35)

Nifty Bank 52455.9 (0.34)

Nifty IT 38911.35 (-0.29)

Nifty Midcap 100 57664.45 (0.86)

Nifty Next 50 74367.35 (0.86)

Nifty Pharma 20844.55 (1.13)

Nifty Smallcap 100 19047.7 (0.52)

15 Jul, EOD - Global

NIKKEI 225 41429.23 (0.58)

HANG SENG 17810.98 (-1.14)

DOW JONES 40211.72 (0.53)

S&P 5631.22 (0.28)


Hot Pursuit News

You are Here : Home > News > Hot Pursuit News >

(15 Jun 2024, 08:51)

Jubilant Pharmova unit to prepay $75 mln term loan

Jubilant Pharmova said that its subsidiary, Jubilant Pharma Holdings Inc., USA (JPHI) has issued a notice to its lenders to voluntary prepay $75 million term loan, equivalent to Rs 626 crore, by the next interest payment date i.e. 24th June 2024.


Jubilant Pharma Holdings Inc., USA (JPHI) is a wholly-owned subsidiary of Jubilant Pharma (JPL), which itself is a part of Jubilant Pharmova.

As on 31st March 2024, Jubilant Pharmova reported gross debt at Rs 3,414 crore and net debt at Rs 2,457 crore. on a consolidated basis.

Meanwhile, Jubilant Pharmova said that its subsidiary, Jubilant Draximage Inc., announced an investment of $50 million to expand its (Positron Emission Tomography) PET radiopharmacy network in strategic locations throughout the United States (US).

The US radiopharmaceutical industry is poised to grow from $5 billion in 2023 to $20 billion in 2030 due to the increasing demand of PET imaging and advance radiopharmaceutical therapies.

The company will add 6 PET radiopharmacies in US. It shall be operatio...

More News
More Company News